These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12775627)

  • 1. Relationships between the pharmaceutical industry and patients' organisations.
    Herxheimer A
    BMJ; 2003 May; 326(7400):1208-10. PubMed ID: 12775627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry funding of patients' support groups: objectives of patients, clinicians, and industry are similar.
    Lapsley PM
    BMJ; 2003 Aug; 327(7410):343-4. PubMed ID: 12907504
    [No Abstract]   [Full Text] [Related]  

  • 3. Industry funding of patients' support groups: declaration of competing interests is rare in Italian breast cancer associations.
    Mosconi P
    BMJ; 2003 Aug; 327(7410):344. PubMed ID: 12907506
    [No Abstract]   [Full Text] [Related]  

  • 4. Health care lobbying in the United States.
    Landers SH; Sehgal AR
    Am J Med; 2004 Apr; 116(7):474-7. PubMed ID: 15047037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patient groups accept money from drug companies? Yes.
    Kent A
    BMJ; 2007 May; 334(7600):934. PubMed ID: 17478845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The illusion of invulnerability.
    Mansfield PR
    BMJ; 2007 May; 334(7602):1020. PubMed ID: 17510114
    [No Abstract]   [Full Text] [Related]  

  • 7. How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study.
    Lau E; Fabbri A; Mintzes B
    Aust Health Rev; 2019 Aug; 43(4):474-480. PubMed ID: 30021681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patient groups accept money from drug companies? No.
    Mintzes B
    BMJ; 2007 May; 334(7600):935. PubMed ID: 17478846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancerbackup sets record straight.
    Rule J
    BMJ; 2007 May; 334(7602):1020. PubMed ID: 17510115
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug companies told that sponsoring patients' groups might help win approval for their products.
    Burton B
    BMJ; 2005 Dec; 331(7529):1359. PubMed ID: 16339237
    [No Abstract]   [Full Text] [Related]  

  • 11. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
    Morin K; Morse LJ
    Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
    [No Abstract]   [Full Text] [Related]  

  • 12. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1193-6. PubMed ID: 12775622
    [No Abstract]   [Full Text] [Related]  

  • 14. US specialty societies are urged to adopt code on relations with industry.
    Tanne JH
    BMJ; 2010 Apr; 340():c2246. PubMed ID: 20418248
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmaceutical industry and disease mongering. Will industry's latest moves promote public health or private profit?
    McKechnie S
    BMJ; 2002 Jul; 325(7357):216; author reply 216. PubMed ID: 12143862
    [No Abstract]   [Full Text] [Related]  

  • 16. Unhealthy spin.
    Burton B; Rowell A
    BMJ; 2003 May; 326(7400):1205-7. PubMed ID: 12775626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The public health office and its partners: perspectives on cooperation between public health offices and self-help organizations].
    Niermann T
    Gesundheitswesen; 1995 Nov; 57(11):715-7. PubMed ID: 8580594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical industry agenda setting in mental health policies.
    Gosden R; Beder S
    Ethical Hum Sci Serv; 2001; 3(3):147-59. PubMed ID: 15278977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.
    Studdert DM; Mello MM; Brennan TA
    N Engl J Med; 2004 Oct; 351(18):1891-900. PubMed ID: 15509824
    [No Abstract]   [Full Text] [Related]  

  • 20. Pens and other pharmaceutical industry gifts.
    Brody H
    Am J Bioeth; 2003; 3(3):58-60. PubMed ID: 14594497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.